ASHLEY VON BERGEN: Open Payments
NPI 1811631609 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 62 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $793 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $238 |
| Lilly USA, LLC | 10 | $198 |
| AstraZeneca Pharmaceuticals LP | 5 | $189 |
| GlaxoSmithKline, LLC. | 6 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| ABBVIE INC. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 6 | $53 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| Exact Sciences Corporation | 2 | $29 |
Products named: AIRSUPRA, KISUNLA, Ozempic, TRELEGY ELLIPTA, Kerendia, Auvelity, MOUNJARO, Wegovy.
Industry payments across AL — which companies pay providers there.
